These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. Katsanos K; Karnabatidis D; Kitrou P; Spiliopoulos S; Christeas N; Siablis D J Endovasc Ther; 2012 Apr; 19(2):263-72. PubMed ID: 22545894 [TBL] [Abstract][Full Text] [Related]
8. Stenosis of transjugular intrahepatic portosystemic shunts: presentation and management. Sterling KM; Darcy MD AJR Am J Roentgenol; 1997 Jan; 168(1):239-44. PubMed ID: 8976952 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study. Lai CC; Fang HC; Tseng CJ; Liu CP; Mar GY J Vasc Interv Radiol; 2014 Apr; 25(4):535-41. PubMed ID: 24529550 [TBL] [Abstract][Full Text] [Related]
10. Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial. Krankenberg H; Tübler T; Ingwersen M; Schlüter M; Scheinert D; Blessing E; Sixt S; Kieback A; Beschorner U; Zeller T Circulation; 2015 Dec; 132(23):2230-6. PubMed ID: 26446728 [TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty. Her AY; Shin ES; Lee JM; Garg S; Doh JH; Nam CW; Koo BK Int J Cardiovasc Imaging; 2018 Sep; 34(9):1339-1347. PubMed ID: 29696453 [TBL] [Abstract][Full Text] [Related]
12. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation. Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559 [TBL] [Abstract][Full Text] [Related]
13. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. Kitrou PM; Spiliopoulos S; Katsanos K; Papachristou E; Siablis D; Karnabatidis D J Vasc Interv Radiol; 2015 Mar; 26(3):348-54. PubMed ID: 25542635 [TBL] [Abstract][Full Text] [Related]
15. Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model. Buszman PP; Tellez A; Afari ME; Peppas A; Conditt GB; Rousselle SD; McGregor JC; Stenoien M; Kaluza GL; Granada JF JACC Cardiovasc Interv; 2013 Aug; 6(8):883-90. PubMed ID: 23968706 [TBL] [Abstract][Full Text] [Related]
16. Angiographic and Clinical Outcomes After Treatment of Femoro-Popliteal Lesions with a Novel Paclitaxel-Matrix-Coated Balloon Catheter. Tepe G; Gögebakan Ö; Redlich U; Tautenhahn J; Ricke J; Halloul Z; Meyer DR; Waliszewski M; Schnorr B; Zeller T; Müller-Hülsbeck S; Ott I; Albrecht T Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1535-1544. PubMed ID: 28660441 [TBL] [Abstract][Full Text] [Related]